This accredited course co-ordinates specialist contributions from clinical scientists, consultants, clinical networks and departments. It uses facilities from Newcastle University and Newcastle Hospitals NHS Foundation Trust. The course offers specialist pathways in medical physics and physiological sciences and is available to the healthcare science workforce and through competitive national recruitment.
This specialist course runs under the NHS Scientist Training Programme (STP) and is accredited by the National School for Healthcare Science Accreditation Unit. Combining academic and workplace learning, the formal teaching element is delivered through structured residential teaching blocks and online study.
There are two pathways.
Medical Physics offers specialisms in:
-Radiation safety physics
-Imaging with ionising radiation
-Imaging with non-ionising radiation
Physiological Sciences offers specialisms in:
-Respiratory and sleep science
HOW TO APPLY:
To study on these courses you will need to apply through the National School of Healthcare Science - Scientist Training Programme.
The site includes frequently asked questions about application and eligibility.
The Faculty of Medical Sciences website has further information about Medical Physics and Physiological Sciences pathways.
We invite postgraduate research proposals in a number of disease areas that impact significantly on patient care. We focus on exploring the mechanisms of disease, understanding the ways disease impacts patients’ lives, utilising new diagnostic and therapeutic techniques and developing new treatments.
As a student you will be registered with a University research institute, for many this is the Institute for Cellular Medicine (ICM). You will be supported in your studies through a structured programme of supervision and training via our Faculty of Medical Sciences Graduate School.
We undertake the following areas of research and offer MPhil, PhD and MD supervision in:
Newcastle hosts one of the most comprehensive organ transplant programmes in the world. This clinical expertise has developed in parallel with the applied immunobiology and transplantation research group. We are investigating aspects of the immunology of autoimmune diseases and cancer therapy, in addition to transplant rejection. We have themes to understand the interplay of the inflammatory and anti-inflammatory responses by a variety of pathways, and how these can be manipulated for therapeutic purposes. Further research theme focusses on primary immunodeficiency diseases.
There is strong emphasis on the integration of clinical investigation with basic science. Our research include:
We also research the effects of UVR on the skin including mitochondrial DNA damage as a UV biomarker.
This area emphasises on translational research, linking clinical- and laboratory-based science. Key research include:
Focus is on applied research and aims to underpin future clinical applications. Technology-oriented and demand-driven research is conducted which relates directly to health priority areas such as:
This research is sustained through extensive internal and external collaborations with leading UK and European academic and industrial groups, and has the ultimate goal of deploying next-generation diagnostic and therapeutic systems in the hospital and health-care environment.
There is a number of research programmes into the genetics, immunology and physiology of kidney disease and kidney transplantation. We maintain close links between basic scientists and clinicians with many translational programmes of work, from the laboratory to first-in-man and phase III clinical trials. Specific areas:
We have particular interests in:
Novel non-invasive methodologies using magnetic resonance are developed and applied to clinical research. Our research falls into two categories:
Our studies cover a broad range of topics (including diabetes, dementia, neuroscience, hepatology, cardiovascular, neuromuscular disease, metabolism, and respiratory research projects), but have a common theme of MR technical development and its application to clinical research.
We focus on connective tissue diseases in three, overlapping research programmes. These programmes aim to understand:
This research theme links with other local, national and international centres of excellence and has close integration of basic and clinical researchers and hosts the only immunotherapy centre in the UK.
Genetic approaches to the individualisation of drug therapy, including anticoagulants and anti-cancer drugs, and in the genetics of diverse non-Mendelian diseases, from diabetes to periodontal disease, are a focus. A wide range of knowledge and experience in both genetics and clinical sciences is utilised, with access to high-throughput genotyping platforms.
Our scientists and clinicians use in situ cellular technologies and large-scale gene expression profiling to study the normal and pathophysiological remodelling of vascular and uteroplacental tissues. Novel approaches to cellular interactions have been developed using a unique human tissue resource. Our research themes include:
We also have preclinical molecular biology projects in breast cancer research.
We conduct a broad range of research activities into acute and chronic lung diseases. As well as scientific studies into disease mechanisms, there is particular interest in translational medicine approaches to lung disease, studying human lung tissue and cells to explore potential for new treatments. Our current areas of research include:
Our research projects are concerned with the harmful effects of chemicals, including prescribed drugs, and finding ways to prevent and minimise these effects. We are attempting to measure the effects of fairly small amounts of chemicals, to provide ways of giving early warning of the start of harmful effects. We also study the adverse side-effects of medicines, including how conditions such as liver disease and heart disease can develop in people taking medicines for completely different medical conditions. Our current interests include: environmental chemicals and organophosphate pesticides, warfarin, psychiatric drugs and anti-cancer drugs.
Our new School of Pharmacy has scientists and clinicians working together on all aspects of pharmaceutical sciences and clinical pharmacy.
The MSc in Medical Ultrasound programme is both academic and vocational in nature and is the only MSc of this type to offer a clinical attachment as part of the course.
The MSc aims to train students to use research and development skills to develop the field of medical ultrasound. Students can choose one of two sub specialities:
MSc in Medical Ultrasound – Vascular (Course Code: A3A1)
MSc in Medical Ultrasound – Echocardiography (Course Code: A3A2)
You will be placed in a clinical attachment at Imperial College Healthcare NHS Trust.
Attending 5 days per week for the duration of the course. (this is included in the fee)
Students should not expect to be scanning every day and hardly at all in the 1st term.
MSc in Medical Ultrasound – Vascular (Course Code: A3A124)
You must already be working in a suitable vascular dept elsewhere. You will have to attend lectures and tutorials one day per week from October – March and any exam dates.
There is only one intake per year, in October. Registration usually opens in November/December the year before and will continue until all places are full.
Places on the course are very limited (25) and we receive 100’s of applications so early application is strongly advised.
Your application will only be reviewed if submitted with all College requirements and has two recent academic references. It will not proceed any further without these.
Applicants should note that this is an academic course and does not entitle you to become a sonographer. This course is not CASE registered.
Further exams would have to be taken by either the: